Akero Therapeutics Inc. (AKRO)
Akero Therapeutics Statistics
Share Statistics
Akero Therapeutics has 79.72M shares outstanding. The number of shares has increased by 15.14% in one year.
| 79.72M |
| 15.14% |
| 14.07% |
| 99.99% |
| n/a |
| 59 |
| n/a |
Short Selling Information
The latest short interest is 6.3M, so 7.9% of the outstanding shares have been sold short.
| 6.3M |
| 7.9% |
| 8.13% |
| 4.73 |
Valuation Ratios
The PE ratio is -7.41 and the forward PE ratio is -12.11. Akero Therapeutics's PEG ratio is -0.25.
| -7.41 |
| -12.11 |
| 0 |
| 12.7 |
| 2.49 |
| -8.12 |
| -0.25 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Akero Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 19.38, with a Debt / Equity ratio of 0.05.
| 19.38 |
| 19.38 |
| 0.05 |
| -0.13 |
| -0.16 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-3,653,043.48 |
| 69 |
| 0 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by 152.46% in the last 52 weeks. The beta is -0.16, so Akero Therapeutics's price volatility has been lower than the market average.
| -0.16 |
| 152.46% |
| 42.25 |
| 36.17 |
| 69.93 |
| 1,442,252 |
Balance Sheet
The company has 340.24M in cash and 36.46M in debt, giving a net cash position of 303.78M.
| 340.24M |
| 36.46M |
| 303.78M |
| -826.16M |
| 1.16B |
| 670.71M |
Cash Flow
In the last 12 months, operating cash flow was -230.11M and capital expenditures 0, giving a free cash flow of -230.11M.
| -230.11M |
| n/a |
| -230.11M |
| -3.43 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
AKRO does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for AKRO is $76.5, which is 42.1% higher than the current price. The consensus rating is "Strong Buy".
| $76.5 |
| 42.1% |
| Strong Buy |
| 8 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 28.93 |
| 2 |